NLS Biotech News

Biotech Business – November 19, 2026

Asgard wins EUR 2.5 million EIC grant

Asgard Therapeutics has been awarded a EUR 2.5 million grant from the European Innovation Council (EIC) Accelerator to move its lead program, AT-108, toward clinical trials in 2027. The grant also makes the company eligible for up to EUR 10 million in equity investment from the EIC Fund.

Sponsored content

ViewLinc Cloud Suite supports life science innovation from laboratory to regulated operations

Vaisala introduces ViewLinc Cloud Suite, a cloud-based environmental monitoring solution that helps organizations start professional-quality monitoring immediately and scale as needs evolve, complemented by Vaisala Care for ViewLinc lifecycle services in selected markets.

Biotech Business – November 18, 2026

Xbrane secures GMP import authorization

Xbrane Biopharma has received authorization from the Swedish Medical Products Agency to import medicinal products from outside the EU/EEA and to certify and release batches for supply within the EU. The approval is expected to simplify the supply chain for its ranibizumab biosimilar Ximluci/Lucamzi, including deliveries of finished product to the US.

Sponsored content

Build a Targeted Biomarker Strategy for Your Program

Turn biological signals into meaningful development insights with a biomarker strategy tailored to your program. 

Biotech Business – November 16, 2026

LifeGlue raises EUR 705,000 seed round

Tampere University spin-out LifeGlue Technologies raises EUR 705,000 in seed funding from business angels in Finland, Estonia, and Lithuania, together with Innovestor. The money will go toward pharmaceutical-grade production of its material for growing human tissue in the lab.

Clinical trials

Profiles in Biotech

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.